LipocineLPCN
13F holders, Q1 2026 (March 31)At the end of Q1 2026, 47 institutions reported holding Lipocine Inc. (LPCN) in their 13F filings, up 21 from Q4 2025. 20 opened new positions and 2 sold out. The largest holders were Ikarian Capital, LLC ($4.1M), Squadron Capital Management LLC ($3.6M) and Eversept Partners, LP ($2.4M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Lipocine Inc.
- CUSIP
- 53630X203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 20 | $11.3M |
| Exits | 2 | $1K |
All 13F filers, Q4 2025 → Q1 2026: 1,830,797 shares bought and 355,339 shares sold, net +1,475,458 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 47 holders
| Ikarian Capital, LLC | 0.58% | Add +154.9% | 508,556 | $4.1M |
| Squadron Capital Management LLC | 1.44% | Reduce -15.1% | 450,000 | $3.6M |
| Eversept Partners, LP | 0.16% | New | 294,989 | $2.4M |
| Rosalind Advisors, Inc. | 0.73% | New | 221,616 | $1.8M |
| Vanguard Capital Management LLC | 0.00% | — | 200,668 | $1.6M |
| AIGH Capital Management LLC | 0.33% | New | 200,000 | $1.6M |
| Stempoint Capital LP | 0.25% | New | 160,420 | $1.3M |
| Boothbay Fund Management, LLC | 0.03% | Add +155.9% | 140,487 | $1.1M |
| Seven Fleet Capital Management LP | 0.31% | New | 124,942 | $998K |
| Birchview Capital, LP | 0.51% | New | 111,786 | $893K |
| BlackRock, Inc. | 0.00% | No change | 89,272 | $713K |
| Mink Brook Asset Management LLC | 0.30% | New | 66,812 | $534K |
| Geode Capital Management, LLC | 0.00% | Add +1.1% | 63,135 | $505K |
| Exome Asset Management LLC | 0.29% | New | 60,861 | $486K |
| Diadema Partners LP | 0.17% | Reduce -80.8% | 50,000 | $400K |
| J. Goldman & Co LP | 0.02% | New | 42,170 | $337K |
| Renaissance Technologies | 0.00% | Add +2.9% | 38,497 | $308K |
| Two Sigma Investments, LP | 0.00% | New | 33,750 | $270K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 32,413 | $259K |
| Citadel Advisors | 0.00% | New | 29,088 | $232K |
| Susquehanna International Group, LLP | 0.00% | Reduce 0.0% | 24,908 | $199K |
| ADAR1 Capital Management, LLC | 0.01% | New | 23,180 | $185K |
| State Street Corp. | 0.00% | Add +20.3% | 22,407 | $179K |
| Jane Street Group, LLC | 0.00% | Add +89.4% | 20,027 | $160K |
| Dimensional Fund Advisors LP | 0.00% | Add +57.5% | 19,122 | $153K |
| XTX Topco Ltd | 0.00% | New | 17,923 | $143K |
| Persistent Asset Partners Ltd | 0.04% | Reduce -81.0% | 13,442 | $107K |
| Northern Trust Corp. | 0.00% | Reduce -0.9% | 13,042 | $104K |
| Prelude Capital Management, LLC | 0.01% | New | 12,630 | $101K |
| Ameriprise Financial Inc. | 0.00% | Reduce -28.9% | 11,448 | $91K |
| Barclays PLC | 0.00% | New | 9,412 | $75K |
| UBS Group AG | 0.00% | Reduce -37.6% | 3,494 | $28K |
| Wells Fargo & Company | 0.00% | New | 2,706 | $22K |
| Vanguard Global Advisers, LLC | 0.00% | — | 1,691 | $14K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 933 | $7K |
| FMR LLC | 0.00% | Add +713.0% | 626 | $5K |
| Morgan Stanley | 0.00% | Reduce -23.6% | 574 | $5K |
| Caldwell Sutter Capital, Inc. | 0.00% | No change | 471 | $4K |
| JPMorgan Chase & Co. | 0.00% | New | 392 | $3K |
| Osaic Holdings, Inc. | 0.00% | Add +21.2% | 143 | $1K |
| Group One Trading LLC | 0.00% | Reduce -18.5% | 132 | $1K |
| PlanVest Financial, Inc | 0.00% | — | 111 | $887 |
| SBI Securities Co., Ltd. | 0.00% | No change | 67 | $535 |
| Tidemark, LLC | 0.00% | No change | 59 | $471 |
| Bogart Wealth, LLC | 0.00% | New | 3 | $24 |
| Farther Finance Advisors, LLC | 0.00% | New | 1 | $9 |
| Royal Bank of Canada | 0.00% | Reduce -31.5% | 50 | $0 |
"% of holder's portfolio" is LPCN's weight in each manager's 13F, not the share of Lipocine Inc. the manager owns.